期刊文献+

大肠癌门静脉插管化疗预防肝转移 被引量:1

Preventing Hepatic Metastasis by Port Vein Infussion on the Patients with Large Bowel Cancer
暂未订购
导出
摘要 目的 :探讨大肠癌根治术门静脉插管 5 -Fu化疗预防肝转移的疗效。方法 :87例DukesB、C期大肠癌患者 ,随机双盲分组 :根治性切除加门静脉化疗 45例 (治疗组 )及单纯根治性切除 42例 (对照组 )。治疗组于根治术当日即以 5 -Fu 1g持续 2 4小时门静脉滴注化疗 7天 ;对照组住院期间不作辅助化疗。结果 :治疗组肝转移发生率明显低于对照组 ,DukesC期术后 3 ,5年生存率也显著高于对照组 ,DukesB ,期无明显差异。结论 :大肠癌根治术门静脉插管预防性化疗 ,可有效降低肝转移的发生率 ,提高DukesC期患者 3、5年生存率。 Objective:To investigate the effect of the chemotherapy by port vein infussion (PVI) to prevent hepatic metastasis on the patients with large bowel cancer.Methods:After radical resection ,87 patients with large bowel cancer were randomly divided into 2 groups, the therapy group received 5-Fu (1.0g/d, continued 7d) chemotherapy by PVI the poeration day. The control group did not receive any chemotherapy during the time in the hospital.Results:The rate of liver metastasis in the therapy group was lower than in the control group and the rate of 3 and 5-year-survival had no difference in stage Dukes B, but it was higher in the chemotherapy of PVI group than the control group in stage Dukes C.Conclusions:5-Fu chemotherapy by PVI after radical resection in the patients with large bowel cancer may decrease the liver metastasis rate and raise the 3 and 5-year-survival rate in stage Dukes C.
出处 《交通医学》 2002年第5期510-512,共3页 Medical Journal of Communications
关键词 预防 肝转移 大肠癌 门静脉插管化疗 DUKES分期 Large bowel cancer Port vein infussion Hepatic metastasis
  • 相关文献

参考文献8

  • 1[1]Gibert HA.Metastasis tumor growth.Stuttgart,New York 1980; 224
  • 2[2]Ekberg H,Tranberg KG,Anderson R,et al.Pattern of recurfence in liver resection for colorectal secondaries.World J Surg 1987; 11:541~547
  • 3[3]Stangl R,Altendorf-Hofman A,Chamley RM,et al.Factors influencing the natural history of colorectal liver metastases.Lancet 1994;343:1405
  • 4[4]Archer SG,Gray Bn.Vascularization of small liver metastases.BrJ Surg 1989;76:545~548
  • 5[5]Spayer JL,Srgarbaker PH,Collins JM.Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans.CancerRes 1981;41:1916~1922
  • 6[6]Rafique M,Adachi W,Shiohara E.Establishment of an experimental model for continous intraportal infusion of chemoimmunotherapeutic agents in the rat.Anticancer Res 1995; 15:1869~1872
  • 7[7]Ishida H,Iwama T,Mishima Y.The significance of portal vein chemotherapy for liver micrometastasis:an experimental study of a rat model.Surg Today 1994;24:900~905
  • 8[8]Wereldsma JC,Bruggink ED,Meijer WS,et al.Adjuvant portal liver infusion in colorectal cancer with 5-fluorouracil heparin versus urokinase versus control:results of a prospective randomized clinical trial (colorectal adenocarcinoma trial I).Cancer 1990;65:425~432

同被引文献11

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部